Compare NFE & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NFE | QTRX |
|---|---|---|
| Founded | 2014 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil/Gas Transmission | Biotechnology: Laboratory Analytical Instruments |
| Sector | Utilities | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 324.4M | 352.7M |
| IPO Year | 2019 | 2017 |
| Metric | NFE | QTRX |
|---|---|---|
| Price | $1.22 | $6.63 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 3 |
| Target Price | $7.70 | ★ $11.33 |
| AVG Volume (30 Days) | ★ 9.3M | 547.7K |
| Earning Date | 02-27-2026 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,768,624,000.00 | $130,203,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $27.93 | $28.28 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.98 | $4.05 |
| 52 Week High | $16.66 | $12.41 |
| Indicator | NFE | QTRX |
|---|---|---|
| Relative Strength Index (RSI) | 50.87 | 51.24 |
| Support Level | $1.04 | $6.40 |
| Resistance Level | $1.30 | $7.10 |
| Average True Range (ATR) | 0.09 | 0.30 |
| MACD | 0.01 | -0.06 |
| Stochastic Oscillator | 58.33 | 35.61 |
New Fortress Energy Inc is an integrated gas-to-power company. Its business model spans the entire production and delivery chain from natural gas procurement and liquefaction to logistics, shipping, terminals, and conversion or development of a natural gas-fired generation. It has invested in floating, liquefied natural gas vessels to lower the cost of acquiring gas while securing a long-term supply for its terminals. Its segments include Terminals & Infrastructure, and Ships. It generates the majority of its revenue from the Terminals & Infrastructure segment.
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.